Description:
Spinogenix, Inc., a preclinical stage, privately-held pharmaceutical company developing drugs to reverse synapse loss and restore connections lost to neurodegenerative diseases. The company's neurorestorative compounds are designed to restore synapses in order to enhance brain connections and improve memory.